Concurrently, chronic inflammation in AA can spread to the skin, inhibiting keratinocyte proliferation and downregulating FLG expression, thereby further aggravating AD-associated barrier dysfunction and establishing a vicious cycle. This evidence concerns the gene FLG and Alzheimer disease.